Locations:
Search
Five-year project builds on long-standing Cleveland Clinic, IBM collaboration
Center for Transformative Nanomedicine awards $1.2 million to researchers from Cleveland Clinic and The Hebrew University
Trial results may not reflect what will be seen in patients
3,000 riders participated over three-day weekend
Findings result in no further development of MDCO-216
Adding PCSK9 inhibitor to statins dropped cholesterol levels to lowest ever studied in a major clinical trial
10-Year, 24,081-patient study raises safety concerns about ibuprofen and naproxen
